Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 40

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

372

HTML

2935

Figures (1-2)

192

Tables (1-4)

163

Sum=3662

Publishing Process of This Article

Item

Count

Browse

996

Download

1061

Sum=2057

Oct 28, 2013 (publication date) through Aug 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 28, 2013; 19(40): 6834-6841
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6834

Full Size Figure Download Figure

Figure 1 Study patient flow. HCC: Hepatocellular carcinoma; CHB: Chronic hepatitis B.

Citation: Jun CH, Hong HJ, Chung MW, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B. World J Gastroenterol 2013; 19(40): 6834-6841
URL: https://www.wjgnet.com/1007-9327/full/v19/i40/6834.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i40.6834